# IRS Upholds Marijuana Dispensary Tax Enforcement Decision > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/marijuana-dispensary-tax-enforcement-irs-rejection/ > **Published:** 2026-04-01T00:02:13-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:33:21-04:00 > **Clinical Summary:** Explore marijuana dispensary tax enforcement and IRS rejection impacts on cannabis businesses and patient access in this detailed analysis. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Patient Access[Healthcare Policy](https://cedclinic.com/cannabis-legalization-in-canada-new-opportunities/)[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/)[Healthcare Economics](https://cedclinic.com/cannabis-industry-medical-neglect-market-patient-impact/)Regulatory Barriers Why This Matters Tax compliance challenges in cannabis businesses directly impact patient access by driving up operational costs and limiting dispensary viability. When the IRS maintains strict enforcement on cannabis businesses, these financial pressures often translate to higher patient costs and reduced access to medical cannabis. Clinical Summary The IRS upheld its rejection of a marijuana dispensary’s offer in compromise, maintaining its position that cannabis businesses face limited tax relief options due to federal scheduling. This reflects the ongoing tension between state-legal medical cannabis programs and federal tax enforcement, where dispensaries cannot deduct standard business expenses under Section 280E of the tax code. The ruling reinforces that cannabis businesses operate under a punitive tax structure that can result in effective tax rates exceeding 70%. Dr. Caplan’s Take “This isn’t just a tax story—it’s a patient access story. When dispensaries face crushing tax burdens with no relief mechanisms, those costs inevitably flow to patients who often lack insurance coverage for their medicine.” Clinical Perspective 🧠 Clinicians should understand that tax enforcement decisions like this contribute to the high cost of medical cannabis for patients. When counseling patients about treatment costs, factor in that dispensary pricing reflects these extraordinary tax burdens. Consider discussing cost-mitigation strategies and advocate for patients who may struggle with affordability due to these systemic barriers. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20IRS%27s%20rejection%20of%20marijuana%20dispensary%27s%20offer%20in%20compromise%20upheld%20-%20The%20Tax%20A...%20%40drcaplan&url=https%3A//www.thetaxadviser.com/issues/2026/mar/irss-rejection-of-marijuana-dispensarys-offer-in-compromise-upheld/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.thetaxadviser.com/issues/2026/mar/irss-rejection-of-marijuana-dispensarys-offer-in-compromise-upheld/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20IRS%27s%20rejection%20of%20marijuana%20dispensary%27s%20offer%20in%20compromise%20upheld%20-%20The%20Tax%20A...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.thetaxadviser.com/issues/2026/mar/irss-rejection-of-marijuana-dispensarys-offer-in-compromise-upheld/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.thetaxadviser.com/issues/2026/mar/irss-rejection-of-marijuana-dispensarys-offer-in-compromise-upheld/](https://www.thetaxadviser.com/issues/2026/mar/irss-rejection-of-marijuana-dispensarys-offer-in-compromise-upheld/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news) - [What are the main topic areas covered in this cannabis-related healthcare news?](#What_are_the_main_topic_areas_covered_in_this_cannabis-related_healthcare_news) - [Why is this cannabis news considered clinically relevant for healthcare providers?](#Why_is_this_cannabis_news_considered_clinically_relevant_for_healthcare_providers) - [What does the “New” designation mean for this healthcare news?](#What_does_the_8220New8221_designation_mean_for_this_healthcare_news) - [How does this news relate to healthcare economics and patient access?](#How_does_this_news_relate_to_healthcare_economics_and_patient_access) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the content contains emerging findings or policy developments that healthcare professionals should monitor closely. #### What are the main topic areas covered in this cannabis-related healthcare news? The article covers four key areas: Patient Access, [Healthcare Policy](https://cedclinic.com/cannabis-legalization-in-canada-new-opportunities/), Medical Cannabis, and [Healthcare Economics](https://cedclinic.com/cannabis-industry-medical-neglect-market-patient-impact/). These topics indicate the news likely addresses how cannabis policy changes affect [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) and healthcare systems. #### Why is this cannabis news considered clinically relevant for healthcare providers? The content is marked as having “Notable Clinical Interest” because it likely contains emerging findings or policy developments in medical cannabis. Healthcare providers need to stay informed about cannabis-related changes that could impact patient treatment options. #### What does the “New” designation mean for this healthcare news? The “New” label indicates this is recently published or updated information. This suggests the cannabis-related developments discussed are current and may represent the latest changes in policy or clinical understanding. #### How does this news relate to healthcare economics and patient access? The inclusion of both Healthcare Economics and Patient Access tags suggests the news covers how cannabis policy or clinical developments affect healthcare costs and patient ability to access treatment. This intersection is important for understanding the broader healthcare system implications. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “IRS’s rejection of marijuana dispensary’s offer in compromise upheld – The Tax Adviser”, “url”: “https://www.thetaxadviser.com/issues/2026/mar/irss-rejection-of-marijuana-dispensarys-offer-in-compromise-upheld/”, “datePublished”: “2026-03-31T23:02:08Z”, “about”: “irs s rejection marijuana dispensary s”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Navigating IRC Section 280E — Critical Updates for Cannabis Taxpayers as the 2025 Filing …](https://cedclinic.com/cannabis-tax-code-challenges-2025-updates-taxpayers/) Learn about the latest updates on IRC Section 280E and how it affects cannabis taxpayers in the upcoming 2025 filing season. [Read More](https://cedclinic.com/cannabis-tax-code-challenges-2025-updates-taxpayers/) [Michigan's 24% marijuana tax tied to Gov. Whitmer's road plan challenged in new lawsuit](https://cedclinic.com/24-marijuana-tax-lawsuit-michigan-cannabis-policy-challenge/) Explore the legal challenges surrounding Michigan's 24% marijuana tax and its implications for cannabis businesses. [Learn More](https://cedclinic.com/24-marijuana-tax-lawsuit-michigan-cannabis-policy-challenge/) [Michigan Treasury releases guidance on new 24% wholesale marijuana tax](https://cedclinic.com/2026-cannabis-wholesale-tax-impact-michigan/) Get detailed guidance from Michigan Treasury on the new 24% wholesale marijuana tax affecting dispensaries and businesses. [Discover Details](https://cedclinic.com/2026-cannabis-wholesale-tax-impact-michigan/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).